Progesterone rapidly recruits female-typical opioid-induced hyperalgesic mechanisms

[1]  R. Bodnar,et al.  Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: Central mechanisms of action and roles of gonadal hormones , 2010, Hormones and Behavior.

[2]  M. Staňková,et al.  Sex-specific Mediation of Opioid-induced Hyperalgesia by the Melanocortin-1 Receptor , 2010, Anesthesiology.

[3]  P. Darbon,et al.  Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms , 2008, PAIN.

[4]  P. Micevych,et al.  Estradiol regulation of progesterone synthesis in the brain , 2008, Molecular and Cellular Endocrinology.

[5]  B. Kest,et al.  Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment , 2008, Neuropharmacology.

[6]  M. Edwards,et al.  Symptoms , 2008, The Lancet.

[7]  J. Pintar,et al.  Nociception increases during opioid infusion in opioid receptor triple knock-out mice , 2007, Neuroscience.

[8]  B. Kest,et al.  Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: Evidence for multiple diverse hyperalgesic systems , 2006, Brain Research.

[9]  E. Wala,et al.  Characterization of morphine-induced hyperalgesia in male and female rats , 2005, Pain.

[10]  E. Chesler,et al.  Acute progesterone can recruit sex-specific neurochemical mechanisms mediating swim stress-induced and κ-opioid analgesia in mice , 2004, Hormones and Behavior.

[11]  V. Hruby,et al.  Antinociceptive and nociceptive actions of opioids. , 2004, Journal of neurobiology.

[12]  J. Mogil,et al.  Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time , 2004, Pain.

[13]  A. Walf,et al.  Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase , 2004, Brain Research.

[14]  F. Colpaert,et al.  Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance. , 2003, Trends in pharmacological sciences.

[15]  C. Rivat,et al.  Opioid-induced hyperalgesia: abnormal or normal pain? , 2003, Neuroreport.

[16]  P. Popik,et al.  Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. , 2001, European journal of pharmacology.

[17]  K. Shen,et al.  Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia , 2001, Brain Research.

[18]  C. Frye,et al.  Progesterone in Conjunction With Estradiol Has Neuroprotective Effects in an Animal Model of Neurodegeneration , 1999, Pharmacology Biochemistry and Behavior.

[19]  S. Hansen,et al.  Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long‐term administration?: Six case histories , 1998, Acta anaesthesiologica Scandinavica.

[20]  S. Russek,et al.  Neurosteroid modulation of recombinant ionotropic glutamate receptors , 1998, Brain Research.

[21]  M. Kavaliers,et al.  Sex differences in N-methyl-d-aspartate involvement in κ opioid and non-opioid predator-induced analgesia in mice , 1997, Brain Research.

[22]  H. Gutstein.  The effects of pain on opioid tolerance: how do we resolve the controversy? , 1996, Pharmacological reviews.

[23]  K. Nelson,et al.  Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. , 1992, Endocrinology.

[24]  A. Caraceni,et al.  Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine , 1991, Pain.

[25]  M. Kavaliers,et al.  Analgesic effects of the progesterone metabolite, 3α-hydroxy-5α-pregnan-20-one, and possible modes of action in mice , 1987, Brain Research.

[26]  C. Inturrisi,et al.  Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. , 1986, The Journal of pharmacology and experimental therapeutics.

[27]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[28]  M. Kavaliers,et al.  Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice. , 1987, Brain research.